Skip to Content

ST-246 Approval Status

  • FDA approved: No
  • Brand name: ST-246
  • Company: SIGA Technologies, Inc.
  • Treatment for: Exposure to Smallpox Virus

ST-246 is an orally active, smallpox antiviral in development to treat individuals exposed to the smallpox virus in the event of an outbreak.

Development Status and FDA Approval Process for ST-246

Apr  4, 2008SIGA Initiates Manufacture of ST-246 NDA Registration Batches
Mar 24, 2008SIGA Files Application Supporting Emergency Use Approval for ST-246

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.